New insights into the open artery hypothesis

Circulation Research

Volumn 103, Issue 1, 2008, Pages 1-3

  Kloner, Robert A ^a,b   Hwang, Hyosook ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Infarct expansion; Myocardial infarction; Reperfusion; Ventricular dilation; Ventricular remodeling

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; CARRIER PROTEIN; COLLAGEN; GATA4 PROTEIN, RAT; SARCOSIN PROTEIN, RAT; TRANSCRIPTION FACTOR GATA 4;

ACUTE HEART INFARCTION; ANEURYSM SURGERY; CELL THERAPY; CLINICAL TRIAL; CORONARY ARTERY LIGATION; CORONARY REPERFUSION; CORONARY STENT; EDITORIAL; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HUMAN; HYPOTHESIS; INTROSPECTION; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; BIOSYNTHESIS; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; MALE; METABOLISM; METHODOLOGY; MORTALITY; NOTE; PATHOLOGY; PATHOPHYSIOLOGY; RAT; TIME; WISTAR RAT;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; COLLAGEN; FIBROBLASTS; GATA4 TRANSCRIPTION FACTOR; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; TIME FACTORS; VENTRICULAR REMODELING;

EID: 48049083101     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.180216     Document Type: Editorial

References (19)

1. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium. The open artery hypothesis. Circulation. 1993;88: 2426-2436.
2. Kloner RA, Leor J, Birnbaum Y. Remodeling, hibernation, and stunning. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJS, eds. Heart Failure. New York: Churchill Livingstone; 1997: 109-125.
3. Reimer KA, Jennings RB. The wavefront phenomenon of myocardial ischemic cell death, II: Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow Lab Invest. 1979;40:633-644.
4. Kloner RA, Ellis SG, Lange R, Braunwald E. Studies of experimental coronary artery reperfusion: effects on infarct size, myocardial function, biochemistry, ultrastructure, and microvascular damage. Circulation. 1983;68 (Suppl I):I-8-I-15.
5. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild C. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
6. Pfeffer MA, Lamas GA, Vaughan DF, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med. 1988;319:80-86.
7. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1849-1906.
8. Muller-Ehmsen J, Peterson KL, Kedes L, Whittaker P, Dow JS, Long TI, Laird PW, Kloner RA. Rebuilding a damaged heart: Long-term survival of transplanted neonatal rat cardiomyocytes after myocardial infarction and effect on cardiac function. Circulation. 2002;105:1720-1726.
9. Dai W, Wold L, Dow J, Kloner RA. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: A novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol. 2005;46:714-719.
10. Landa N, Miller L, Feinberg MS, Holbova R, Shachar M, Freeman I, Cohen S, Leor J. Effect of injectable alginate implant on cardiac remodeling and function after recent and old infarcts in rat. Circulation. 2008;117:1388-1396.
11. Schwarz ER, Speakman MT, Kloner RA. A new model of ventricular plication: A suturing technique to decrease left ventricular dimensions, improve contractility, and attenuate ventricular remodeling after myocardial infarction in the rat heart. J Cardiovascular Pharmacology and Therapeutics. 2000;5:41-49.
12. Nakagawa M, Takemura G, Kanamori H, Goto K, Maruyama R, Tsujimoto A, Ohno T, Okada H, Ogino A, Esaki M, Miyata S, Li L, Ushikoshi H, Aoyama T, Kawasaki M, Nagashima K, Fujiwara T, Minatoguchi S, Fujiwara H. Mechanisms by which late coronary reperfusion mitigates postinfarction cardiac remodeling. Circ Res. 2008; 103: 98-106.
13. Reffelmann T, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation. 2003;108:2911-2917.
14. Hammerman H, Schoen FJ, Braunwald E, Kloner RA. Drug induced expansion of infarct: Morphologic and functional correlations. Circulation. 1984;69:611-617.
15. Hochman JS, Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation. 1987;75: 299-306.
16. Hale SL, Kloner RA. Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion. Am Heart J. 1988;116:1508-1513.
17. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL, for the Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395-2407.
18. Eaton LW, Weiss JL, Bulkley BH, Garrison JB, Weisfeldt ML. Regional cardiac dilatation after acute myocardial infarction: two-dimensional echocardiography. N Engl J Med. 1979;300:57-62.
19. Dzavik V, Buller CE, Lamas GA, Rankin JM, Mancini GBJ, Cantor WJ, Carere RJ, Ross JR, Atchinson D, Forman S, Thomas B, Buszman P, Vozzi C, Glanz A, Cohen EA, Meciar P, Devlin G, Mascette A, Sopko G, Knatterud GL, Hochman JS, for the TOSCA-2 Investigators. Randomized trial of percutaneous coronary intervention for subacute infarct - related coronary occlusion to achieve long-term patency and improve ventricular function. The Total Occlusion Study of Canada (TOSCA) - 2 Trial. Circulation. 2006; 114:2449-2457.